EMV has continued to impress with a tight capital structure and overwhelming demand. Capital Raise loose stock has been mostly absorbed in its pull back from $0.99 back down to $0.66. Once supply dwindled it was quite clear the bulls are fully in charge of the EMV trend.
A C&H formation with a cup spread of 33.5c and what appears to be handle forming the last weekly session, although proper confirmation is still required this could indicated a continuation pattern with a target of $1.27.
With material news nearing as EMVision continues pushing forward through its Pilot Clinical trial, the price action could coincide well with the expected news flow. Additionally the potential for a Research Grant through EMV's partner 'Australian Stroke Alliance' in the event it was successful could see a significant rerate and possibly fiscally pave the way for all future trial expenses. (I stress that this is not a certainty, but I am optimistic of EMV's chances.)
EMV is an easy hold for me, with a 2-3 year vision in my trading plan.